• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Revisiting baseline 18F-FDG PET/CT parameters: Key considerations for prognostic evaluation in primary CNS lymphoma.重新审视基线18F-FDG PET/CT参数：原发性中枢神经系统淋巴瘤预后评估的关键考量因素
Neuro Oncol. 2025 Jun 21;27(5):1402-1403. doi: 10.1093/neuonc/noaf052.
2
The Role Of 18F-FDG PET/CT In Evaluation Of Primary CNS Lymphoma: The Path Less Travelled.18F-FDG PET/CT 在原发性中枢神经系统淋巴瘤评估中的作用：未走过的路。
J Pak Med Assoc. 2023 Aug;73(8):1744-1746. doi: 10.47391/JPMA.23-59.
3
Enhancing prognostication and treatment response evaluation in primary CNS lymphoma with 18F-FDG-PET/CT.利用18F-FDG-PET/CT增强原发性中枢神经系统淋巴瘤的预后评估和治疗反应评估。
Neuro Oncol. 2024 Dec 5;26(12):2377-2387. doi: 10.1093/neuonc/noae146.
4
Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.18F-FDG PET及PET/CT在免疫功能正常的原发性中枢神经系统淋巴瘤患者中的诊断价值：一项系统评价和Meta分析
Oncotarget. 2017 Jun 20;8(25):41518-41528. doi: 10.18632/oncotarget.17456.
5
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.治疗前18F-FDG PET/CT在原发性脑淋巴瘤中的预后作用
Ann Nucl Med. 2018 Oct;32(8):532-541. doi: 10.1007/s12149-018-1274-8. Epub 2018 Jul 7.
6
Prognostic Impact of Quantitative Changes Between Baseline and Interim 18 F-FDG PET/CT in Pediatric Classic Hodgkin Lymphoma.基线与中期18F-FDG PET/CT定量变化对儿童经典型霍奇金淋巴瘤的预后影响
Clin Nucl Med. 2025 Jul 1;50(7):e407-e416. doi: 10.1097/RLU.0000000000005874. Epub 2025 Mar 31.
7
Axillary staging with 18F-FDG PET/CT in early breast cancer: impact of tumor subtypes.18F-FDG PET/CT用于早期乳腺癌腋窝分期：肿瘤亚型的影响
Ann Saudi Med. 2025 May-Jun;45(3):145-153. doi: 10.5144/0256-4947.2025.145. Epub 2025 Jun 5.
8
18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.18F-FDG PET、FDG-PET/CT 联合 MRI 评估淋巴瘤分期中的骨髓浸润：系统评价和荟萃分析。
Eur J Radiol. 2012 Feb;81(2):303-11. doi: 10.1016/j.ejrad.2010.11.020. Epub 2010 Dec 9.
9
The utility of quantitative F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer.定量F-FDG PET/CT衍生参数作为预测放射性碘难治性分化型甲状腺癌总生存期的预后因素的效用。
Asia Ocean J Nucl Med Biol. 2025;13(2):156-165. doi: 10.22038/aojnmb.2025.84029.1596.
10
18F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis.18F-FDG PET/CT用于检测不明原发癌颈外转移成人患者的原发肿瘤：一项系统评价和荟萃分析
Medicine (Baltimore). 2017 Apr;96(16):e6713. doi: 10.1097/MD.0000000000006713.

本文引用的文献

1
Prognostic value of [F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies.基于[F]FDG PET/CT 预测颅内淋巴瘤患者接受伊布替尼治疗的预后价值。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3940-3950. doi: 10.1007/s00259-021-05386-0. Epub 2021 May 8.
2
Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions.数字与模拟 PET/CT：靶病灶和参照区 SUVmax 的受试者内比较。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1745-1750. doi: 10.1007/s00259-018-4256-0. Epub 2019 Jan 7.
3
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.治疗前18F-FDG PET/CT在原发性脑淋巴瘤中的预后作用
Ann Nucl Med. 2018 Oct;32(8):532-541. doi: 10.1007/s12149-018-1274-8. Epub 2018 Jul 7.

Revisiting baseline 18F-FDG PET/CT parameters: Key considerations for prognostic evaluation in primary CNS lymphoma.

作者信息

Oh Minyoung, Cho Hyungwoo, Yoon Dok Hyun, Kim Jae Seung

机构信息

Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Neuro Oncol. 2025 Jun 21;27(5):1402-1403. doi: 10.1093/neuonc/noaf052.

DOI:10.1093/neuonc/noaf052
PMID:40249127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12199152/
Abstract
摘要